Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression.

Küçükibrahimoğlu E, Saygin MZ, Calişkan M, Kaplan OK, Unsal C, Gören MZ.

Eur J Clin Pharmacol. 2009 Jun;65(6):571-7. doi: 10.1007/s00228-009-0650-7. Epub 2009 Apr 17.

PMID:
19373461
2.

Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram.

Brennan BP, Admon R, Perriello C, LaFlamme EM, Athey AJ, Pizzagalli DA, Hudson JI, Pope HG Jr, Jensen JE.

Psychiatry Res Neuroimaging. 2017 Nov 30;269:9-16. doi: 10.1016/j.pscychresns.2017.08.009. Epub 2017 Sep 1.

PMID:
28892734
3.

Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram?

Khazaie H, Rahimi M, Tatari F, Rezaei M, Najafi F, Tahmasian M.

Neurosciences (Riyadh). 2011 Jan;16(1):42-5.

PMID:
21206443
4.

Evaluation of the role of NMDA receptor function in antidepressant-like activity. A new study with citalopram and fluoxetine in the forced swim test in mice.

Wolak M, Siwek A, Szewczyk B, Poleszak E, Bystrowska B, Moniczewski A, Rutkowska A, Młyniec K, Nowak G.

Pharmacol Rep. 2015 Jun;67(3):490-3. doi: 10.1016/j.pharep.2014.12.003. Epub 2014 Dec 17.

PMID:
25933959
5.

Effects of citalopram and fluoxetine on the corticocerebral blood flow in conscious rabbits.

Sas K, Csete K, Vezekényi Z, Sztriha L, Vécseil L, Papp JG.

Acta Physiol Hung. 2007 Sep;94(3):167-77.

PMID:
17853768
6.

Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial.

Leombruni P, Amianto F, Delsedime N, Gramaglia C, Abbate-Daga G, Fassino S.

Adv Ther. 2006 May-Jun;23(3):481-94.

PMID:
16912031
7.

Dietary supplementation with glutamine and γ-aminobutyric acid improves growth performance and serum parameters in 22- to 35-day-old broilers exposed to hot environment.

Hu H, Bai X, Shah AA, Wen AY, Hua JL, Che CY, He SJ, Jiang JP, Cai ZH, Dai SF.

J Anim Physiol Anim Nutr (Berl). 2016 Apr;100(2):361-70. doi: 10.1111/jpn.12346. Epub 2015 May 17.

PMID:
25980810
8.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
9.

Elevated basal glutamate and unchanged glutamine and GABA in refractory epilepsy: Microdialysis study of 79 patients at the yale epilepsy surgery program.

Çavuş I, Romanyshyn JC, Kennard JT, Farooque P, Williamson A, Eid T, Spencer SS, Duckrow R, Dziura J, Spencer DD.

Ann Neurol. 2016 Jul;80(1):35-45. doi: 10.1002/ana.24673. Epub 2016 Jun 13.

PMID:
27129611
10.

Comparing effects of citalopram with fluoxetine on sleep quality in patients with major depressive disorder.

Shahsavand-Ananloo E, Berenji F, Sadeghniiat K, Alimadadi A, Zahiroddin AR, Tabatabaee M, Abbasi-Asl M, Ghaeli P.

Eur Rev Med Pharmacol Sci. 2013 May;17(9):1155-61.

11.

Plasma levels of citalopram in depressed patients with hepatitis C.

Gleason OC, Yates WR, Philipsen MA, Isbell MD, Pollock BG.

Psychosomatics. 2004 Jan-Feb;45(1):29-33.

PMID:
14709758
12.

Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.

Jiménez-Jiménez FJ, Molina JA, Vargas C, Gómez P, Navarro JA, Benito-León J, Ortí-Pareja M, Gasalla T, Cisneros E, Arenas J.

J Neurol Sci. 1996 Sep 15;141(1-2):39-44.

PMID:
8880690
13.

Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?

Castrogiovanni P, Blardi P, De Lalla A, Dell'Erba A, Auteri A.

Psychopharmacol Bull. 2003 Spring;37(2):102-8.

PMID:
14566218
14.

Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice.

Patris M, Bouchard JM, Bougerol T, Charbonnier JF, Chevalier JF, Clerc G, Cyran C, Van Amerongen P, Lemming O, Høpfner Petersen HE.

Int Clin Psychopharmacol. 1996 Jun;11(2):129-36.

PMID:
8803650
15.

Citalopram as treatment of depression in patients with epilepsy.

Specchio LM, Iudice A, Specchio N, La Neve A, Spinelli A, Galli R, Rocchi R, Ulivelli M, de Tommaso M, Pizzanelli C, Murri L.

Clin Neuropharmacol. 2004 May-Jun;27(3):133-6.

PMID:
15190237
16.

Alteration of plasma glutamate and glutamine levels in children with high-functioning autism.

Shimmura C, Suda S, Tsuchiya KJ, Hashimoto K, Ohno K, Matsuzaki H, Iwata K, Matsumoto K, Wakuda T, Kameno Y, Suzuki K, Tsujii M, Nakamura K, Takei N, Mori N.

PLoS One. 2011;6(10):e25340. doi: 10.1371/journal.pone.0025340. Epub 2011 Oct 5.

17.

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors.

Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R.

Redox Rep. 2003;8(6):365-70.

PMID:
14980069
18.

Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.

Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J, Drevets WC, Charney DS.

Biol Psychiatry. 2005 Dec 15;58(12):969-73. Epub 2005 Jul 25.

PMID:
16043137
19.

Fluoxetine versus other types of pharmacotherapy for depression.

Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2013 Jul 17;(7):CD004185. Review.

PMID:
24353997
20.

Citalopram and fluoxetine affects blood chemistry, hematology and brain serotonin in rats.

Ebuehi OA, Akinbode AA, Erinfolami AR, Badaru AA, Yusuf MA, Ojajuni MO.

Nig Q J Hosp Med. 2013 Apr-Jun;23(2):94-8.

PMID:
24579503

Supplemental Content

Support Center